Home / Publications / Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones

Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones

Andrey Nikolaevich Komogortsev 1
Andrey Nikolaevich Komogortsev
, 
Boris Valer'evich Lichitsky 1
Boris Valer'evich Lichitsky
, 
Konstantin Sergeevich Krylov 1
Konstantin Sergeevich Krylov
, 
Arkady Anatol'evich Dudinov 1
Arkady Anatol'evich Dudinov
, 
Petr Petrovich Purygin 2
Petr Petrovich Purygin
, 
Mikhail Mikhailovich Krayushkin 1
Mikhail Mikhailovich Krayushkin
10.1016/j.mencom.2014.04.012
Published 2014-04-16
Communication , Volume 24, Issue 3, 161-162
5
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Komogortsev A. N. et al. Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones // Mendeleev Communications. 2014. Vol. 24. No. 3. pp. 161-162.
GOST all authors (up to 50) Copy
Komogortsev A. N., Lichitsky B. V., Krylov K. S., Dudinov A. A., Purygin P. P., Krayushkin M. M. Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones // Mendeleev Communications. 2014. Vol. 24. No. 3. pp. 161-162.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2014.04.012
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2014.04.012
TI - Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones
T2 - Mendeleev Communications
AU - Komogortsev, Andrey Nikolaevich
AU - Lichitsky, Boris Valer'evich
AU - Krylov, Konstantin Sergeevich
AU - Dudinov, Arkady Anatol'evich
AU - Purygin, Petr Petrovich
AU - Krayushkin, Mikhail Mikhailovich
PY - 2014
DA - 2014/04/16
PB - Mendeleev Communications
SP - 161-162
IS - 3
VL - 24
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2014_Komogortsev,
author = {Andrey Nikolaevich Komogortsev and Boris Valer'evich Lichitsky and Konstantin Sergeevich Krylov and Arkady Anatol'evich Dudinov and Petr Petrovich Purygin and Mikhail Mikhailovich Krayushkin},
title = {Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones},
journal = {Mendeleev Communications},
year = {2014},
volume = {24},
publisher = {Mendeleev Communications},
month = {Apr},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2014.04.012},
number = {3},
pages = {161--162},
doi = {10.1016/j.mencom.2014.04.012}
}
MLA
Cite this
MLA Copy
Komogortsev, Andrey Nikolaevich, et al. “Recyclization of 1-aryl-4-iminoimidazolidin-2-ones on treatment with hydrazine: Synthesis of 5-arylaminomethyl-2,4-dihydro[1,2,4]triazol-3-ones.” Mendeleev Communications, vol. 24, no. 3, Apr. 2014, pp. 161-162. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2014.04.012.

Abstract

Treatment of 4-imino-N-arylimidazolidin-2-ones with hydrazine causes recyclization to afford 5-arylaminomethyl-2,4-dihydro[1,2,4]- triazol-3-ones.

References

1.
Reactions forming and recyclizing heterocycles
Shvaika O.P., Artemov V.N., Baranov S.N.
Chemistry of Heterocyclic Compounds, 1970
2.
10.1016/j.mencom.2014.04.012_bib0010
Varbanov
Acta Crystallogr.,, 2009
3.
Hydantoins as antitumor agents
Rodgers T.R., LaMontagne M.P., Markovac A., Ash A.B.
Journal of Medicinal Chemistry, 1977
5.
A diastereoselective synthesis of pseudopeptidic hydantoins by an Ugi/cyclization/Ugi sequence
Sañudo M., García-Valverde M., Marcaccini S., Torroba T.
Tetrahedron, 2012
6.
10.1016/j.mencom.2014.04.012_bib0030
Sharma
J. Chem. Pharm. Res., 2012
7.
M. T. Bilodeau, C. Chen, N.D. P. Cosford, B.W. Eastman, J.C. Hartnett, E.H. Hu, P.J. Manley, L.A. Neilson, L.R. Tehrani and Z. Wu, US Patent WO 2005/100356, 2005.
8.
2(S)-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3(S)-phenyl-4-((3-oxo-1,2,4-triazol- 5-yl)methyl)morpholine (1):  A Potent, Orally Active, Morpholine-Based Human Neurokinin-1 Receptor Antagonist
Hale J.J., Mills S.G., MacCoss M., Shah S.K., Qi H., Mathre D.J., Cascieri M.A., Sadowski S., Strader C.D., MacIntyre D.E., Metzger J.M.
Journal of Medicinal Chemistry, 1996
9.
Arylazanylpyrazolone Derivatives as Inhibitors of Mutant Superoxide Dismutase 1 Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
Zhang Y., Benmohamed R., Huang H., Chen T., Voisine C., Morimoto R.I., Kirsch D.R., Silverman R.B.
Journal of Medicinal Chemistry, 2013
10.
J. W. Hanifin, R.Z. Gussin, E. Cohen and P. River, US Patent 1977/4,044,021, 1977.